# Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544

> **NCT07563894** · PHASE1 · RECRUITING · sponsor: **Pfizer** · enrollment: 16 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-07799933 tablets with PF-07799544 fasted
- **DRUG:** PF-07799933 film-coated tablets with PF-07799544 fasted
- **DRUG:** PF-07799933 film-coated tablets with PF-07799544 fed
- **DRUG:** PF-07799933 film-coated tablets fasted
- **DRUG:** PF-07799933 film-coated tablets following rabeprazole pretreatment fasted

## Key facts

- **NCT ID:** NCT07563894
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-10
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-06-23
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07563894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07563894, "Relative Bioavailability and Impact of Rabeprazole for PF-07799933, Food-Effect for PF-07799933 and PF-07799544". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07563894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*